Skip to main content
SpringerLink
Log in

Nutrition and Hyperglycemia Management in the Inpatient Setting (Meals on Demand, Parenteral, or Enteral Nutrition)

  • Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The goal of this paper is to provide the latest evidence and expert recommendations for management of hospitalized patients with diabetes or hyperglycemia receiving enteral (EN), parenteral (PN) nutrition support or, those with unrestricted oral diet, consuming meals on demand.

Recent Findings

Patients with and without diabetes mellitus commonly develop hyperglycemia while receiving EN or PN support, placing them at increased risk of adverse outcomes, including in-hospital mortality. Very little new evidence is available in the form of randomized controlled trials (RCT) to guide the glycemic management of these patients. Reduction in the dextrose concentration within parenteral nutrition as well as selection of an enteral formula that diminishes the carbohydrate exposure to a patient receiving enteral nutrition are common strategies utilized in practice. No specific insulin regimen has been shown to be superior in the management of patients receiving EN or PN nutrition support. For those receiving oral nutrition, new challenges have been introduced with the most recent practice allowing patients to eat meals on demand, leading to extreme variability in carbohydrate exposure and risk of hypo and hyperglycemia.

Summary

Synchronization of nutrition delivery with the astute use of intravenous or subcutaneous insulin therapy to match the physiologic action of insulin in patients receiving nutritional support should be implemented to improve glycemic control in hospitalized patients. Further RCTs are needed to evaluate glycemic and other clinical outcomes of patients receiving nutritional support. For patients eating meals on demand, development of hospital guidelines and policies are needed, ensuring optimization and coordination of meal insulin delivery in order to facilitate patient safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Diabetes Care in the Hospital. Diabetes Care 2017; 40 Suppl 1: S120-S127. Up-to date concise reference guding management of hyperglycemia in hospitalized patients.

  2. Ryan DB, Swift CS. The mealtime challenge: nutrition and glycemic control in the hospital. Diabetes Spectrum. 2014;27:163–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Curll M, Dinardo M, Noschese M, Korytkowski MT. Menu selection, glycaemic control and satisfaction with standard and patient- controlled consistent carbohydrate meal plans in hospitalized patients with diabetes. Qual Saf Health Care. 2010;19:355–9.

    Article  PubMed  Google Scholar 

  4. Goldman DP, Variana M, Romley JA. The emerging improtance of patient amenities in hospital care. N Engl J Med. 2010;363:2185–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. McKnight KA, Carter L. From trays to tube feeding: overcoming the challenge of hospital nutrition and glycemic control. Diabetes Spectrum. 2008;21:233–40.

    Article  Google Scholar 

  6. Hirose M, Yamanaka H, Ishikawa E, Sai A, Kawamura T. Easy and flexible carbohydrate counting sliding scale reduces blood glucose of hospitalized diabetic pateint in safety. Diabetes Res Clin Prac. 2011;93:404–9.

    Article  CAS  Google Scholar 

  7. Dungan KM, Sagrilla C, Abdel-Rasoul M, Osei K. Prandial insulin dosing using carbohydrate counting technique in hispitalized patient with type 2 diabetes. Diabetes Care. 2013;36:3476–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Thurber KM, Dierkhising RA, Reiland SA, Pearson KK, Smith SA, O’Meara JG. Mealtime insuin dosing by carbohydrate counting in hospitalized cardiology patients: a retrospective cohort study. Diabetes Technol Ther. 2015;11:1–7.

    Google Scholar 

  9. Cohen LS, Sedhom L, Salifu M, Friedman EA. Inpatient diabetes management: examining morning practice in an acute care setting. Diabetes Educator. 2007;33:483–92.

    Article  PubMed  Google Scholar 

  10. Korytkowski M, Draznin B, Drincic A. Food, fasting, insulin and glycemic control in the hospital. In: DrazninB, editor. Managing diabetes and hyperglycemia in the hospital setting. Alexandria: The American Diabetes Association; 2016. P 70–83.

  11. Pleva M, Mirtallo JM, Steinberg SM. Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition. Nutr Clin Pract. 2009;24:626–34.

    Article  PubMed  Google Scholar 

  12. •• Olveira G, Tapia MJ, Ocón J, et al. Prevalence of diabetes, prediabetes, and stress hyperglycemia: insulin therapy and metabolic control in patients on total parenteral nutrition (prospective multicenter study). Endocr Pract. 2015;21(1):59–67. Large prospective multicenter trial examining the prevalence of diabetes, prediabetes, and stress hyperglycemia prior to initiation of PN therapy and the subsequent development of hyperglycemia.

    Article  PubMed  Google Scholar 

  13. Arinzon Z, Shabat S, Shuval I, et al. Prevalence of diabetes mellitus in elderly patients received enteral nutrition long-term care service. Arch Gerontol Geriatr. 2008a;47:383–93.

    Article  PubMed  Google Scholar 

  14. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Ramirez-Perez C. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001a;10:482–90.

    Article  CAS  PubMed  Google Scholar 

  15. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009a;373:1798–807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lelkes BR, Unsworth PI. Lelkes. Reactive oxygen species, apoptosis and altered NGF induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy. Neurotox Res. 2001;3:189–203.

    Article  CAS  PubMed  Google Scholar 

  17. Ling PR, Mueller C, Smith RJ, et al. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism. 2003;52:868–74.

    Article  CAS  PubMed  Google Scholar 

  18. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Phys. 1998;275:H721–5.

    CAS  Google Scholar 

  19. Petrov MS, Zagainov VE. Influence of enteral versus parenteral nutrition on blood glucose control in acute pancreatitis: a systematic review. Clin Nutr. 2007;26:514.

    Article  CAS  PubMed  Google Scholar 

  20. Suchner U, Senftleben U, Eckart T, et al. Enteral versus parenteral nutrition: effects on gastrointestinal function and metabolism. Nutrition. 1996;12:13–22.

    Article  CAS  PubMed  Google Scholar 

  21. Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367–71.

    Article  PubMed  Google Scholar 

  22. Lin LY, Lin HC, Lee PC, Ma WY, Lin HD. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci. 2007;333:261–5.

    Article  PubMed  Google Scholar 

  23. Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33:739–41.

    Article  PubMed  Google Scholar 

  24. Sarkisian S, Fenton TR, Shaheen AA, Raman M. Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients is associated with higher mortality. Can J Gastroenterol. 2010;24:453–7.

    Article  PubMed  PubMed Central  Google Scholar 

  25. • Olveira G, Tapia MJ, Ocón J, et al. Parenteral nutrition-associated hyperglycemia in non- critically ill inpatients increases the risk of in-hospital mortality (multicenter study). Diabetes Care. 2013;36(5):1061–6. Largest study looking at hyperglycemia during PN and mortality in non critically ill patients

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. • Farrokhi F, Chandra P, Smiley D, Pasquel FJ, Peng L, Newton CA, et al. Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition. Endocr Pract. 2014;20:41–5. This is the only study that looked at clinical outcomes and glycemic variability in patients receiving PN.

    Article  PubMed  Google Scholar 

  27. Lee H, Koh SO, Park MS. Higher dextrose delivery via TPN related to the development of hyperglycemia in non-diabetic critically ill patients. Nutr Res Pract. 2011;5(5):450–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gosmanov AR, Umpierrez GE. Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep. 2013 Feb;13(1):155–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ahrens CL, Barletta JF, Kanji S, Tyburski JG, Wilson RF, Janisse JJ, et al. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit Care Med. 2005;33:2507–12.

    Article  CAS  PubMed  Google Scholar 

  30. •• McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. The Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr. 2016;40:159–211. The latest guidelines reviewing the evidence beyond appropriate use of EN and PN support.

  31. Valero MA, León-Sanz M, Escobar I, Gomis P, de la Cámara A, Moreno JM. Evaluation of non-glucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr. 2001 Dec;55(12):1111–6.

    Article  CAS  PubMed  Google Scholar 

  32. Opara EC, Petro A, Tevrizian A, et al. L-Glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. J Nutr. 1996;126:273–9.

    CAS  PubMed  Google Scholar 

  33. Grau T, Bonet A, Minambres E, et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med. 2011;39:1263–8.

    Article  CAS  PubMed  Google Scholar 

  34. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489–97.

    Article  CAS  PubMed  Google Scholar 

  35. Lidder P, Flanagan D, Fleming S, et al. Combining enteral with parenteral nutrition to improve postoperative glucose control. Br J Nutr. 2010;103:1635–41.

    Article  CAS  PubMed  Google Scholar 

  36. Neff K, Donegan D, MacMahon J, O'Hanlon C, Keane N, Agha A, et al. Management of parenteral nutrition associated hyperglycaemia: a comparison of subcutaneous and intravenous insulin regimen. Ir Med J. 2014 May;107(5):141–3.

  37. Sajbel TA, Dutro MP, Radway PR. Use of separate insulin infusions with total parenteral nutrition. J Parenter Enter Nutr. 1987;11:97–9.

    Article  CAS  Google Scholar 

  38. Overett TK, Bistrian BR, Lowry SF, Hopkins BS, Miller D, Blackburn GL. Total parenteral nutrition in patients with insulin-requiring diabetes mellitus. J Am Coll Nutr. 1986;5(1):79–89.

    Article  CAS  PubMed  Google Scholar 

  39. McMahon MM. Management of parenteral nutrition in acutely ill patients with hyperglycemia. Nutr Clin Pract. 2004;19:120–8.

    Article  PubMed  Google Scholar 

  40. Jakoby MG, Nannapaneni N. An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management. JPEN J Parenter Enteral Nutr. 2012;36:183–8.

    Article  CAS  PubMed  Google Scholar 

  41. • Hakeam HA, Mulia HA, Azzam A, Amin T. Glargine insulin use versus continuous regular insulin in diabetic surgical noncritically ill patients receiving parenteral nutrition: randomized controlled study. JPEN J Parenter Enteral Nutr 2016; pii:0148607116644710. This is the only RCT that compared two different treatment approaches.

  42. Nauck MA, Walberg J, Vethacke A, El-Ouaghlidi A, Senkal M, Holst JJ, et al. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. Regul Pept. 2004;118:89–97.

    Article  CAS  PubMed  Google Scholar 

  43. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al., Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012 Jan;97(1):16–38. doi:10.1210/jc.2011-2098.

  44. Maynard G et al; Society of Hospital Medicine Glycemic Control Implementation guide 2016. Section V.3. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. 78–91.

  45. Arinzon Z, Shabat S, Shuval I, et al. Prevalence of diabetes mellitus in elderly patients received enteral nutrition long-term care service. Arch Gerontol Geriatr. 2008b;47:383–93.

    Article  PubMed  Google Scholar 

  46. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Ramirez-Perez C. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001b;10:482–90.

    Article  CAS  PubMed  Google Scholar 

  47. Umpierrez G, Isaacs S, Bazargan N, You X, Thaler L, Kitabchi A. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.

    Article  CAS  PubMed  Google Scholar 

  48. Ertorer ME, Haydarededeoglu FE, Anaforglu I. Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit. Diabetes Res Clin Pract. 2010;90:8–14.

    Article  CAS  PubMed  Google Scholar 

  49. Deane AM, Rayner CK, Keeshan A, et al. The effects of critical illness on intestinal glucose sensing, transporters, and absorption. Crit Care Med. 2014;42:57–65.

    Article  CAS  PubMed  Google Scholar 

  50. Bharucha AE, Camilleri M, Burton DD, et al. Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia. Am J Gastroenterol. 2014;109:1910–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Marathe CS, Rayner CK, Bound M, et al. Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes. Diabetes. 2014;63:2668–75.

    Article  CAS  PubMed  Google Scholar 

  52. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009b;373:1798–807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Lopez Teros MT, Ramirez CF, Aleman-Mateo H. Hyperinsulinemia is associated with the loss of appendicular skeletal muscle mass at 4.6 year follow-up in older men and women. Clin Nutr. 2015;34:931–6.

    Article  CAS  PubMed  Google Scholar 

  54. De Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54:945–55.

    Article  PubMed  Google Scholar 

  55. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107.

    Article  CAS  PubMed  Google Scholar 

  56. Craig LD, Nicholson S, Silverstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition. 1998;14:529–34.

    Article  CAS  PubMed  Google Scholar 

  57. Brown B, Roehl K, Betz M. Enteral nutrition formula selection: current evidence and implications for practice. Nutr Clin Pract. 2015;30:72–85.

    Article  PubMed  Google Scholar 

  58. Visek J, Zourek M, Lacigova S, Rusavy Z. Influence of fiber on glycemic index of enteral nutrition. JPEN J Parenter Enteral Nutr. 2007;31:72–85.

    Article  Google Scholar 

  59. Leon-Sanz M, Garcia-Luna PP, Sanz-Paris A, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). J Parenter Enter Nutr. 2005;29:21–9.

  60. Elia M, Ceriello A, Laube H, et al. Enteral nutritional support and use of diabetes-specific enteral formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005;28:2267–79.

    Article  PubMed  Google Scholar 

  61. Alish CJ, Garvey WT, Maki KC, et al. A diabetes specific formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther. 2010;12:419–25.

    Article  CAS  PubMed  Google Scholar 

  62. Vaisman N, Lansink M, Rouws CH, et al. Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients. Clin Nutr. 2009;28:549–55.

    Article  PubMed  Google Scholar 

  63. Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. J Parenter Enter Nutr. 2009;33:37–49.

    Article  CAS  Google Scholar 

  64. Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomized controlled trial. Eur J Clin Nutr. 2005;59:1221–32.

    Article  CAS  PubMed  Google Scholar 

  65. Yokoyama J, Someya T, Yoshhihara R, Ishii H. Effects of high-monounsaturated fatty acid enteral formula vs high-carbohydrate enteral formula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients. J Int Med Res. 2008;36:137–46.

    Article  CAS  PubMed  Google Scholar 

  66. Mori Y, Ohta T, Tanaka T, Morohoshi Y, Matsuura K, et al. Effects of a low-carbohydrate diabetes-specific formula in tpe 2 diabetic patients during tube feeding evaluated by continuous glucose monitoring. e-SPEN, Eur J Clin Nutr Metab. 2011;6:e68–73.

    Article  Google Scholar 

  67. Ojo O, Brooke J. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients. 2014;6:5142–52.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Mesejo A, Acosta JA, Ortega C, et al. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr. 2003;22:295–305.

    Article  CAS  PubMed  Google Scholar 

  69. • Mesejo A, Montejo-Gonzalez JC, Vaquerizo-Alonso C, Lobo-Tamer G, Zabarte-Martinez M, et al. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study. Critical Care. 2015;19:390. Investigation into the role DSF EN has at improving glycemic outcomes when utilized in critical care patients.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Sanz-Paris A, Boj-Carceller D, Lardies-Sanchez B, Perez-Fernandez L, Cruz-Jentoft AJ. Health-care costs, glycemic control and nutritional status in malnourished older diabetics treated with a hypercaloric diabetes-specific enteral nutritional formula. Nutrients. 8:153.

  71. Han YY, Lai SR, Partridge JS, Wang MY, Sulo S, et al. The clinical and economic impact of the use of diabetes-specific enteral formula on ICU patients with type 2 diabetes. Clin Nutr. 2016; doi:10.1016/j.clnu.2016.09.027.

  72. McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. J Parenter Enter Nutr. 2013;37:23–36.

    Article  CAS  Google Scholar 

  73. • Barazzoni R, et al. Carbohydrates and insulin resistance in clinical nutrition: recommendations from the ESPEN expert group. Clin Nutr. 2016; doi:10.1016/j.Clnu.2016.09.010. Recent guidelines published recommending the use of DSF EN in patients as a means for glycemic management.

  74. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.

    Article  CAS  PubMed  Google Scholar 

  75. De La Rosa GDC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalized in a mixed medical and surgical intensive care unit: a randomized clinical trial. Crit Care. 2008;12:R120.

    Article  Google Scholar 

  76. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190–7.

    Article  CAS  PubMed  Google Scholar 

  77. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–48.

    Article  CAS  PubMed  Google Scholar 

  78. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.

    Article  Google Scholar 

  79. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU. Chest. 2010;137:544–51.

    Article  CAS  PubMed  Google Scholar 

  80. Korytkowski MT, Salata RJ, Koerbel GL, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009;32:594–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Cook A, Burkitt D, McDonald L, Sublett L. Evaluation of glycemic control using NPH insulin sliding scale vs insulin aspart sliding scale in continuously tube-fed patients. Nutr Clin Pract: Off Publ Am Soc Parenter Enter Nutr. 2009;24:718–22.

    Article  Google Scholar 

  82. Hsia E, Seggelke SA, Gibbs J, et al. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract: Off Publ Am Soc Parenter Enter Nutr. 2011;26:714–7.

    Article  Google Scholar 

  83. • Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes: a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2016; doi:10.1016/s2213-8587(16)30402-8. Investigation into the role of oral hypoglycemic agents utilized in combination with basal insulin for inpatient glycemic management of non-critical care patients.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine: Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, 984120 Nebraska Medical Center, Omaha, NE, 68198-4120, USA

    Andjela T. Drincic & Padmaja Akkireddy

  2. Department of Pharmaceutical and Nutrition Care, University of Nebraska Medical Center, 984120 Nebraska Medical Center, Omaha, NE, 68198-4120, USA

    Jon T. Knezevich

Authors
  1. Andjela T. Drincic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jon T. Knezevich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Padmaja Akkireddy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andjela T. Drincic.

Ethics declarations

Conflict of Interest

Andjela T. Drincic has received consultant honorarium from Bayer.

Jon T. Knezevich and Padmaja Akkireddy declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Hospital Management of Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drincic, A.T., Knezevich, J.T. & Akkireddy, P. Nutrition and Hyperglycemia Management in the Inpatient Setting (Meals on Demand, Parenteral, or Enteral Nutrition). Curr Diab Rep 17, 59 (2017). https://doi.org/10.1007/s11892-017-0882-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-017-0882-3

Keywords

Search

Navigation